KJ103

· Shanghai Bao Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KJ103, covering 2024-08-13 to 2025-06-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial With KJ103 in Anti-GBM Disease [Phase 2]